Tissue expression, distribution, and regulation of PDE5

Area of Science:

• Molecular biology
• Genetics
• Pharmacology

Background:

• Phosphodiesterase 5 (PDE5) exists in three isoforms (PDE5A1, PDE5A2, PDE5A3) with distinct N-terminal sequences.
• PDE5A1 and PDE5A2 are widespread, while PDE5A3 is specific to smooth muscle.
• The PDE5A gene, located on chromosome 4q26, utilizes alternative first exons (A1-A3-A2) for isoform-specific sequences.

Purpose of the Study:

• To elucidate the structural organization of PDE5A gene isoforms and their promoter regions.
• To investigate the regulatory mechanisms of PDE5A gene expression, including response to cyclic nucleotides and Sp1 transcription factor.
• To explore the potential involvement of PDE5A promoters in PDE5 inhibitor tachyphylaxis and hypoxia-related conditions like priapism.

Main Methods:

• Analysis of PDE5A gene structure, including alternative first exons and promoter locations.
• Investigation of promoter activity in response to cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP).
• Identification of Sp1-binding sites within the PDE5A2 promoter and enhancer regions.

Main Results:

• The PDE5A gene features alternative first exons (A1-A3-A2) encoding isoform-specific N-terminal sequences.
• The PDE5A1 and PDE5A2 promoters are responsive to cGMP and cAMP stimulation.
• Sp1-binding sequences are crucial for basal and inducible activity of the PDE5A2 promoter and for PDE5A induction by enhancers.
• Hypoxia may down-regulate PDE5A promoters, suggesting a role in priapism.

Conclusions:

• The differential expression of PDE5A isoforms is regulated by alternative first exons and distinct promoter elements.
• PDE5A promoter activity is modulated by cyclic nucleotides and Sp1 transcription factor.
• PDE5A promoters are implicated in the development of tachyphylaxis to PDE5 inhibitors and potentially in hypoxia-induced priapism.